Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)
Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetration, to Terumo Neuro’s neurovascular portfolio. Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetratio…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Eureka Ergonomic Expands Opal Collection With AURELIA, Bringing Furniture-Inspired Design to the Modern Home Office
- Payhawk expands in Poland to support growing businesses with AI-native spend management
- Payhawk makes Stockholm its Nordic hub in European expansion
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →